The Robert L. Benz and Marie Uberti-Benz Family Prize in Life Sciences & Management is a cash prize awarded each year to a graduating LSM senior who has distinguished him or herself through extraordinary academic achievement and entrepreneurship.
2016: Lucy Chen
Lucy has proven herself an exceptional student, researcher, and leader who has made great contributions to the LSM community in particular and the University in general. From the outset and throughout her time at Penn she has taken great interest in the physician-patient relationship, both as the subject of academic research, and as something she is committed to personally. In LSM, Lucy has served as a peer advisor every year she has been eligible, and been an active member of what started as the LSM Student Events Committee, and is now the LSM Student Advisory Board. Without exception, she has been a terrific help to a great many of her peers, as well as the program leadership, communicating effectively and constructively and offering sage advice. Lucy’s research has been varied and interesting. She started in translational research at the end of freshman year, in the laboratory of Dr. John Maris at Children’s Hospital of Philadelphia, in the field of chemotherapeutics for neuroblastoma where whenever the opportunity arose she would go into the clinic to meet with patients, and staff. What is especially noteworthy for someone so young is that she has given presentations of her research work to senior executives at Novartis, with whom Dr. Maris collaborates on the development of novel strategies for the treatment of neuroblastoma. In addition to translational research, Lucy has worked on an end-of-life decision project, concerned with the science of decision-making. As a consummate communicator, Lucy has shared her passion for research with others by serving as writer and editor for two University-wide publications, Penn Bioethics Journal (of which she was Managing Editor), and Synapse, a healthcare journal. Lucy plans to become an academic physician-investigator, working with patients directly, but focusing on research with the potential for influencing healthcare policy. Her next step on this path is the MD/PhD degree program Harvard Medical School she will be joining in the fall of this year.
2016: Vivek Nimgaonkar
Vivek in LSM is well known for always being willing to give advice to his fellow students even when he is very busy, which has been just about all the time, as indicated by his many and varied accomplishments. Vivek has been a standout leader who sustains and improves community wherever he applies his unique and impressive array of intellectual and interpersonal talents. Among other things, Vivek has led a student science journal (Penn Science), started a health policy group (“Wonk Tank,” a student-led group under the auspices of the Penn Wharton Public Policy Initiative), and helped found a pre-medical society (MedX) based on encouraging the kind of well-rounded approach to preparation for medical school that he has himself exemplified. And even beyond Penn Vivek has had a significant impact, through his voluntary work with local immigrant families, and two internships – one at Cambridge University in the UK where he studied drug discovery productivity on a summer Thouron Award, and another at the Aravind Hospital in Tamil Nadu, India where he conducted health services research. Vivek’s research, at Penn and beyond, has centered on analyzing quantitative data in a rigorous and skeptical—but still idealistic—manner, in a way that has allowed him to rewrite assumptions and narratives that have governed approaches to problems. After graduating, Vivek’s next step is to do research in the laboratory of Dr. Celeste Simon of Penn’s Abramson Family Cancer Research Institute before applying to medical school.
2015: Andrew Hong
Andy was cited by his classmates as being a particularly helpful resource to them during his senior year Capstone course—and indeed he’s been an energetic community-builder throughout his time in LSM. He’s proved himself an ambitious and very able student, and his curiosity and willingness to try new things have been valued attributes both outside and inside the classroom. Even before he came to LSM, Andy filed a patent for a device that warns blind users of overhanging obstacles for which he has raised funds for its development. At Penn, Andy has collaborated with graduate students in working with the Wharton Small Business Development Center in the Commercialization Acceleration Program, and done research with the Department of Bioinformatics at the University of Pennsylvania. Beyond Penn, while in LSM, Andy interned with Shire Pharmaceuticals Human Genetic Therapies, serving as a clinical trial coordinator, and then most recently as an Associate Consultant in the Life Sciences division of Simon-Kucher & Partners. After graduation, Andy will return to consulting as an Analyst with Huron Life Sciences.
2015: Tess Michaels
Tess has proved herself remarkable as a student and, already, as an entrepreneur—and she has not only started up a company (with social good in mind), but brought her sharp and original mind to bear on improving the LSM and the Penn experience for her fellow students. Her ideas to improve the educational experiences at Penn were recognized with the Wharton Dean's Award for Innovation. As a freshman she was elected as a VP of the Class of 2015, and she later served as the EVP of Wharton Finance Club, and the President of the Biotech Society. As the sole winner of the Clarkston Scholarship, she represented LSM and Penn in Pennsylvania BIO events and participated in research projects in various labs. As a sophomore she launched SOCEANA, a social good startup that brought together corporations, non-profits, philanthropists and volunteers to collaborate using “Philas,” a novel social currency. She was honored by the UN Foundation as a Global Woman Entrepreneur to Watch, as part of its Women’s Entrepreneurship Day celebration, and as a result of her appearance in D.C., she was invited by an Editor to write a column in Washington Post. Tess plans to do healthcare investment banking at Goldman Sachs, and subsequently major in healthcare strategy at Harvard Business School. Dr. Steven Nichtberger said of her: “Tess is truly a natural entrepreneur. She is an outstanding example of what is possible when you are passionate about an idea and willing to make a commitment of time and energy. Her ability to motivate companies, non-profits, philanthropists and others to collaborate around SOCEANA is a testament to her leadership and vision.”
2014: Nuvid Bhuiyan
Nuvid, who graduates with an impressive academic record, worked on the Penn synthetic biology research team that won a silver medal in the North American International Genetically Engineered Machine (iGEM) Competition. She was also on the team that won 2nd place in the Wharton Business Plan Competition for a healthcare startup based on an idea for an online doctor's office to connect hospitals to underserved patient populations including those who live in rural areas and the elderly. In addition, Nuvid served as consultant for Penn's Commercialization Acceleration Program, as Program Manager of the Wharton Social Impact/Urban Nutrition Initiative, promoting health and nutrition in West Philadelphia communities, and as Editor-In-Chief of the undergraduate biomedical journal Synapse. Nuvid completed her science internship at Sanofi-Aventis in Paris, and her business internship in healthcare investment banking at Goldman Sachs, where she is returning after graduation.
2013: Dan Newman
Dan has indeed demonstrated extraordinary academic achievement in his Biology and Strategic Management degrees. His leadership qualities have made themselves felt not only through a standout performance with his team in the LSM Capstone course, but also in his serving as a leader with the student events committee here in LSM. Professionally, Dan interned in Clinical Project Management and Operations with Regeneron Pharmaceuticals, performing a variety of analyses of clinical trials and costs for various drugs. He interned too with the Joint BioEnergy Institute in California, where he worked in the lab optimizing a high-throughput plasmid cloning procedure and did other work related to the development of biofuels. His independent study research at HUP was in molecular oncology, centered on melanoma. Extra-curricularly, Dan also served as President the last two years for the Penn Ski and Snowboard Team, organizing weekly ski trips in season, and, of course, introducing innovations that improved the management of the organization. He's also used his talent as a presenter in the service of his school as a Wharton Ambassador.
2012: Stanley Lim
Though the program has very rigorous requirements, Stanley graduated early from LSM and submatriculated into the Master's in Biotechnology program at SEAS. While in LSM, he accumulated various experience in multiple areas of the healthcare industry. For his science internship at Vertex Pharmaceuticals, Stanley undertook protein crystallography for early drug discovery. Subsequently, Stanley worked at BioAdvance, a biotech VC, to screen start-ups and assist portfolio companies. He is currently engaged in a medical device start-up. Stanley has continued to mentor LSM's younger students, serving as a TA for the LSM Capstone and Proseminar courses.
2011: Meera Ragavan
A co-founder of Synapse, Penn’s first student-run health care publication, Meera also served as its Executive Vice-President and played a key role in getting corporate sponsorship and funding for Synapse’s early issues. She also is the co-author of two publications that came out the research she conducted with Dr. Evan Fieldston at the Children’s Hospital of Philadelphia, examining issues in patient flow and hospital admissions patterns. In August 2012, Meera will be starting medical school at Stanford University.
2010: Andrew Ettenger
Upon graduating from LSM, Andrew co-founded SMA Partners, a company that, in response to new regulations in Chile to promote the growth of its biotechnology sector, aimed help startup ventures find funding and licensing opportunities in the U.S. Currently, while continuing to work with a Chilean company developing a new treament for metastatic melanoma, Andrew is a research assistant in the Human Embryonic Stem Cell Core at Children's Hospital of Boston and plans to pursue a PhD in the biological sciences.